Skip to main content

Articles

Page 3 of 66

  1. To investigate the correlation between anthropometric indexes [cardiometabolic index (CMI), lipid accumulation products (LAP), waist triglyceride index (WTI), and body mass index (BMI)] and acute pancreatitis ...

    Authors: Qiu Sun, Qingshuai Ren, Liming Du, Shuohua Chen, Shouling Wu, Bing Zhang and Bangmao Wang
    Citation: Lipids in Health and Disease 2023 22:190
  2. Autonomic remodeling of the atria plays a pivotal role in the development of atrial fibrillation (AF) and exerts a substantial influence on the progression of this condition. Hyperlipidemia is a predisposing f...

    Authors: An Zhang, Huilin Li, Qiyuan Song, Yansong Cui, Yujiao Zhang, Ximin Wang, Zhan Li and Yinglong Hou
    Citation: Lipids in Health and Disease 2023 22:189
  3. The relationship between Insulin resistance (IR) evaluated through homeostasis model assessment insulin resistance (HOMA-IR) and cognitive function is controversial among nondiabetic individuals. No study so f...

    Authors: Baojian Wei, Qianni Dong, Jinlong Ma and Aihua Zhang
    Citation: Lipids in Health and Disease 2023 22:188
  4. Abdominal aortic aneurysms (AAAs) can result in high mortality upon rupture but are usually undiagnosed because of the absence of symptoms in the early stage. Ultrasound screening is regarded as an impactful w...

    Authors: Wenhui Lin, Songyuan Luo, Wei Li, Jitao Liu, Ting Zhou, Fan Yang, Dan Zhou, Yuan Liu, Wenhui Huang, Yingqing Feng and Jianfang Luo
    Citation: Lipids in Health and Disease 2023 22:187
  5. The elevation of TyG is considered an important factor in promoting the progression of non-alcoholic fatty liver disease (NAFLD), but its impact on the degree of liver steatosis remains unclear. This study aim...

    Authors: Mengyuan Wang, Mingxing Chang, Peipu Shen, Wei Wei, Huayao Li and Guifang Shen
    Citation: Lipids in Health and Disease 2023 22:186
  6. Variations in the prevalence and systemic inflammatory (SI) status between non-alcoholic fatty liver disease (NAFLD) and newly defined metabolic dysfunction-associated fatty liver disease (MAFLD) have only bee...

    Authors: Qingdan Liu, Meilan Han, Meilan Li, Xiaoyin Huang, Ruimei Feng, Wanxin Li, Jun Chen, Haiying He, Wenxin Zheng, Zhijian Hu, Shanshan Du and Weimin Ye
    Citation: Lipids in Health and Disease 2023 22:185
  7. Ceramide, a bioactive signaling sphingolipid, has long been implicated in cancer. Members of the ceramide synthase (CerS) family determine the acyl chain lengths of ceramides, with ceramide synthase 4 (CerS4) ...

    Authors: Su-Jeong Kim, Incheol Seo, Min Hee Kim, Joo-Won Park, Shin Kim and Woo-Jae Park
    Citation: Lipids in Health and Disease 2023 22:183
  8. Polyunsaturated fatty acids (PUFAs) have demonstrated significant therapeutic potential across a wide range of disease. The aim of this study was to investigate the potential impact of PUFA intake on the preva...

    Authors: Yong Huang, Yingying Wang, Huiyi Su, Hexi Wang, Haoyu Xu, Chengwei Xu, Fulin Zhou and Yao Zhang
    Citation: Lipids in Health and Disease 2023 22:182
  9. The evidence on the relationship between remnant cholesterol (RC) and stroke remains controversial. Therefore, this study aimed to explore the relationship between RC and stroke risk in a Chinese population of...

    Authors: Yuanqing Wang, Fubing Zha, Yong Han, Ying Cai, Miaoling Chen, Cui Yang, Xiaodong Cai, Haofei Hu, Changchun Cao and Jiao Luo
    Citation: Lipids in Health and Disease 2023 22:181
  10. The impact of total cholesterol (TC) on lumbar bone mineral density (BMD) is a topic of interest. However, empirical evidence on this association from demographic surveys conducted in China is lacking. Therefo...

    Authors: Yongbing Sun, Xin Qi, Xinbei Lin, Yang Zhou, Xue Lv, Jing Zhou, Zhonglin Li, Xiaoling Wu, Zhi Zou, Yongli Li and Hao Li
    Citation: Lipids in Health and Disease 2023 22:180
  11. Preeclampsia (PE) is a new-onset pregnancy-specific disorder with a high prevalence that leads to over 70 000 maternal and 500 000 foetal fatalities worldwide each year. The level of chemerin, a newly identifi...

    Authors: Yangxue Yin, Shuangshuang Xie, Qin Xu, Lingyun Liao, Hongqin Chen and Rong Zhou
    Citation: Lipids in Health and Disease 2023 22:179
  12. The present study analyzes the influence of resistance training (RT) and high-intensity interval training (HIIT) on metabolic indices and serum levels of Sirtuin1 (SIRT1) in postmenopausal women who suffer fro...

    Authors: Saeid Shamlou Kazemi, Ali Heidarianpour and Elnaz Shokri
    Citation: Lipids in Health and Disease 2023 22:177
  13. Dysregulation of lipid metabolism is the most prominent metabolic alteration observed in obesity, cancer, and cardiovascular diseases. The present study aimed to explore the sex differences associated with lip...

    Authors: Tao Li, Wen Meng, Tian Ci Liu, Yi Zhao Wang and Man Zhang
    Citation: Lipids in Health and Disease 2023 22:176
  14. Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder. The primary objective of this study was to identify the major pathogenic mutations in a Chinese family with FH.

    Authors: Xian Lv, Chunyue Wang, Lu Liu, Guoqing Yin, Wen Zhang, Fuad A. Abdu, Tingting Shi, Qingfeng Zhang and Wenliang Che
    Citation: Lipids in Health and Disease 2023 22:175
  15. The widely reported associations between body mass index (BMI) and various chronic diseases, such as hypertension and asthma, have garnered significant attention. Nonetheless, there remains a dearth of researc...

    Authors: Lingxia Song, Jiajin Li, Sen Yu, Yunjia Cai, Huan He, Jiayi Lun, Li Zheng and Jufeng Ye
    Citation: Lipids in Health and Disease 2023 22:174
  16. Mead acid (MA, 5,8,11-eicosatrienoic acid) is an n-9 polyunsaturated fatty acid (PUFA) and a marker of essential fatty acid deficiency, but nonetheless generally draws little attention. MA is distributed in va...

    Authors: Hiroshi Kawashima and Katsuhiko Yoshizawa
    Citation: Lipids in Health and Disease 2023 22:172
  17. Near-infrared irradiation photobiomodulation (NIR-PBM) has been successfully used in periodontal treatment as an adjuvant tool to locally improve cell function and regeneration. Although the relationship betwe...

    Authors: Isadora Martins Ribeiro, Maria Eduarda de Souza Barroso, Edgar Hell Kampke, Larissa Trarbach Figueiredo Braga, Bianca Prandi Campagnaro and Silvana dos Santos Meyrelles
    Citation: Lipids in Health and Disease 2023 22:171
  18. The goal of this research was to determine whether or not there is a saturation effect and whether or not the visceral adiposity index (VAI) correlates with bone mineral density (BMD) in adult Americans.

    Authors: Zi-hao Chen, Ting-feng Zhou, Yi-tian Bu and Lei Yang
    Citation: Lipids in Health and Disease 2023 22:170
  19. Data are limited on the relationship between cardiovascular disease (CVD) and the combinational indices of lipid accumulation product (LAP), triglyceride-glucose index (TyG), and visceral adiposity index (VAI)...

    Authors: Alireza Jafari, Hamid Najafipour, Mitra Shadkam and Sina Aminizadeh
    Citation: Lipids in Health and Disease 2023 22:169
  20. Testosterone (T) is an anabolic hormone crucial to the structure and function of skeletal muscle. Testosterone is partially synthesized from cholesterol, but little is known about the relationship of cholester...

    Authors: Gederson K. Gomes, Flávia M. S. de Branco, Heitor O. Santos, Jaqueline L. Pereira, Fábio L. Orsatti and Erick P. de Oliveira
    Citation: Lipids in Health and Disease 2023 22:168
  21. The criteria for metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) remain controversial. This research aimed to identify a potential biomarker to differentiate the subtypes of obesity.

    Authors: Baowen Yu, Moran Hu, Wanzi Jiang, Yizhe Ma, Jingya Ye, Qinyi Wu, Wen Guo, Yan Sun, Min Zhou, Yiwen Xu, Zhoulu Wu, Yiwen Wang, Sin Man Lam, Guanghou Shui, Jingyu Gu, John Zhong Li…
    Citation: Lipids in Health and Disease 2023 22:166
  22. Non-high-density lipoprotein-cholesterol (non-HDL-C) has been identified as a potential biomarker for metabolic syndrome (MetS). However, its predictive capability for MetS varies among different ethnic groups...

    Authors: Fatemeh Vazirian, Susan Darroudi, Hamid Reza Rahimi, MohamadReza Latifi, Behrouz Shakeri, Samaneh Abolbashari, Amir Hooshang Mohammadpour, Habibollah Esmaily, Mohsen Mouhebati, Sara Samadi and Majid Ghayour Mobarhan
    Citation: Lipids in Health and Disease 2023 22:165
  23. Urinary 3-indoxyl sulfate levels as well as fecal short chain fatty acid (SCFA) concentrations are surrogate markers for gut microbiota diversity. Patients with inflammatory bowel diseases (IBDs) and patients ...

    Authors: Hauke Christian Tews, Tanja Elger, Stefan Gunawan, Tanja Fererberger, Stefanie Sommersberger, Johanna Loibl, Muriel Huss, Gerhard Liebisch, Martina Müller, Arne Kandulski and Christa Buechler
    Citation: Lipids in Health and Disease 2023 22:164
  24. Controlling cholesterol levels is one of the primary goals of preventing atherosclerotic plaque progression in patients undergoing coronary artery bypass graft (CABG) surgery. This study aimed to investigate t...

    Authors: Aryan Ayati, Kasra Akbari, Akbar Shafiee, Arezou Zoroufian, Arash Jalali, Sahar Samimi, Mina Pashang, Kaveh Hosseini, Jamshid Bagheri and Farzad Masoudkabir
    Citation: Lipids in Health and Disease 2023 22:163
  25. The triglyceride-glucose index (TyG index) is an indicator of insulin resistance that has been studied recently. The relationship between insulin resistance and the risk of hypertension has been documented pre...

    Authors: Anna D. Argoty-Pantoja, Rafael Velázquez-Cruz, Joacim Meneses-León, Jorge Salmerón and Berenice Rivera-Paredez
    Citation: Lipids in Health and Disease 2023 22:162
  26. Specific ceramides have been identified as risk markers for cardiovascular disease (CVD) years before onset of disease. Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide has bee...

    Authors: Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, Tommi Suvitaival, Jin Xu, Emilie Hein Zobel, Bernt Johan von Scholten, Rasmus Sejersten Ripa, Andreas Kjaer, Tine Willum Hansen, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing and Cristina Legido-Quigley
    Citation: Lipids in Health and Disease 2023 22:160
  27. Currently, there is limited and controversial clinical research on the correlation between sleep-disordered breathing (SDB) and dyslipidemia. This discrepancy in findings may be because studies that primarily ...

    Authors: Tong Feng, Guangliang Shan, Huijing He, Guo Pei, Jiaoying Tan, Bing Lu and Qiong Ou
    Citation: Lipids in Health and Disease 2023 22:159
  28. Cholesterol metabolism is a risk factor for cardiovascular disease, and recent studies have shown that cholesterol metabolism poses a residual risk of cardiovascular disease even when conventional lipid risk f...

    Authors: Yuxuan Wu, Qinfei Wei, Husheng Li, Han Yang, Yuying Wu, Yiming Yu, Qiansi Chen, Baochang He and Fa Chen
    Citation: Lipids in Health and Disease 2023 22:158
  29. Lipid metabolism disorders are considerably involved in the pathology of atherosclerosis; nevertheless, the fundamental mechanism is still largely unclear. This research sought to examine the function of lipop...

    Authors: Tingting Wang, Zheng Cheng, Ran Zhao, Jin Cheng, He Ren, Pengke Zhang, Pengyun Liu, Qimeng Hao, Qian Zhang, Xiaolei Yu, Dongdong Sun and Dongwei Zhang
    Citation: Lipids in Health and Disease 2023 22:156
  30. Hepatitis C has been associated with the development of hepatic steatosis, which increases the risk of liver cancer. The microsomal triglyceride transporter protein (MTTP), is a lipid transport protein that me...

    Authors: Xiaoxia Wang, Yu Cao, Jia Guo, Dezhao Li, Haitao Zhang, Qingkun Song and Jun Lu
    Citation: Lipids in Health and Disease 2023 22:154
  31. Adipose tissue, which is mainly composed of adipocytes, is a crucial component of the tumor microenvironment, particularly in breast cancer. Adipocytes surround breast cancer cells and may participate in cell‒...

    Authors: Jinna Wu, Jia Li, Huiya Xu, Ni Qiu, Xiaojia Huang and Hongsheng Li
    Citation: Lipids in Health and Disease 2023 22:153
  32. It is well established that the consumption of trans-fatty acids (TFAs) can increase the incidence of total mortality, cardiovascular disease, cancer, and diabetes. However, there are still no demographic stud...

    Authors: Yuancheng Zhou, Chengcheng Wei, Xincheng Gao, Yi Sun and Xiaomin Han
    Citation: Lipids in Health and Disease 2023 22:152
  33. Although generic drugs have been approved with the assurance of interchangeable applications with original drugs, some physicians, and patients still view their efficacy and interchangeability negatively. Usin...

    Authors: Yu-Cheol Lim, Eui-Kyung Lee and Mi-Hai Park
    Citation: Lipids in Health and Disease 2023 22:151
  34. Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease. Metabolism-related genes significantly influence the onset and progression of the disease. Hence, it is necessary to screen metabolism...

    Authors: Hua Jiang, Yang Hu, Zhibo Zhang, Xujia Chen and Jianpeng Gao
    Citation: Lipids in Health and Disease 2023 22:150
  35. This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia.

    Authors: Xiaozhe Chen, Chunlei Hou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xunjie Zhou, Bo Lu and Deyu Fu
    Citation: Lipids in Health and Disease 2023 22:149
  36. Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease with a global prevalence, and modulation of ANGPTL8 expression has emerged as a promising predictor of NAFLD susceptibility. This r...

    Authors: Samira Saghafi, Elham Chamani, Fatemeh Salmani, Reza Fadaei, Efat Shafiei, Nariman Moradi and Tahmine Tavakoli
    Citation: Lipids in Health and Disease 2023 22:147
  37. Lipid metabolism affects type 2 immunity; however, the association between plasma lipids and eosinophilic inflammation in humans is uncertain. This study analysed the relationship between plasma lipids and per...

    Authors: Yu Gao, Xiaocheng Wang, Lan Gao, Xin Li and Weihong Bai
    Citation: Lipids in Health and Disease 2023 22:146
  38. The absence of distinct symptoms in the majority of individuals with metabolic dysfunction-associated fatty liver disease (MAFLD) poses challenges in identifying those at high risk, so we need simple, efficien...

    Authors: Haoxuan Zou, Xiaopu Ma, Fan Zhang and Yan Xie
    Citation: Lipids in Health and Disease 2023 22:145
  39. Lipoprotein (a) [Lp(a)] is an apoB100-containing lipoprotein with high levels being positively associated with atherosclerotic cardiovascular disease. Lp(a) levels are genetically determined. However, previous...

    Authors: Anastasiya Matveyenko, Heather Seid, Kyungyeon Kim, Rajasekhar Ramakrishnan, Tiffany Thomas, Nelsa Matienzo and Gissette Reyes-Soffer
    Citation: Lipids in Health and Disease 2023 22:144
  40. Recent studies have shown that triglyceride glucose-body mass index (TyG-BMI) is associated with the risk of ischemic stroke and coronary artery disease. However, little attention has been given to the associa...

    Authors: Cuixia Zhan, Yuan Peng, Hongjian Ye, Xiangwen Diao, Chunyan Yi, Qunying Guo, Wei Chen and Xiao Yang
    Citation: Lipids in Health and Disease 2023 22:143
  41. Recent studies have shown that loss-of-function mutations in hepatic asialoglycoprotein receptor 1 (ASGR1) are associated with low levels of circulating cholesterol and a reduced risk of coronary artery diseas...

    Authors: Qin Luo, Jingfei Chen, Yingjie Su, Panyun Wu, Jiangang Wang, Zhenfei Fang and Fei Luo
    Citation: Lipids in Health and Disease 2023 22:142
  42. The prognostic value of lipoprotein (Lp) (a) in patients who have suffered from coronary artery disease (CAD) has not been fully studied, and the results are inconsistent. This study was conducted to evaluate ...

    Authors: Lin Zhao, Lin Sun, ZengLei Zhang, KunQi Yang, ZuoZhi Li, Man Wang, Yan Zeng, XianLiang Zhou and WeiXian Yang
    Citation: Lipids in Health and Disease 2023 22:141

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2022 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    82 days submission to accept (Median)

    2022 Usage 
    1,623,217 downloads
    6,558 Altmetric mentions